Jianhua Zhang: Meet the Experts of VIRO 2025

The Global Voices in Renal Oncology (VIRO) Virtual Congress, organized by OncoDaily, will be held on September 11–12, 2025. Chaired by Dr. Rana R. McKay with co-chair Dr. Yüksel Ürün, this year’s program will feature around 50 leading experts in renal oncology from across the globe, sharing cutting-edge updates and future perspectives.

• The congress is free to attend.
• Register via the link.

Co-Chair of VIRO

Images

Name

Rana McKay Professor of Medicine and Urology at UC San Diego Health Co-leader of the GU Oncology Program at Moores Cancer Center As Co-Chair of VIRO, Dr. Rana McKay (University of California, San Diego) opened the congress with her talk on  “Future Directions: Emerging Agents and Combinations.” She emphasized the momentum in renal cell carcinoma (RCC) research, highlighting how novel immunotherapies, targeted drugs, and rational combination strategies are reshaping patient care. Dr. McKay underscored the importance of personalized, biomarker-driven approaches and global collaboration, aiming to optimize survival and quality of life worldwide.

Spotlight on Jianhua Zhang

Dr. Zhang is Chief Physician, Associate Professor, and Deputy Director at the Department of Nuclear Medicine at Peking University First Hospital in Beijing, China.

At the Global Voices in Renal Oncology (VIRO) Virtual Congress 2025, Dr. Zhang will present on “Novel Imaging Integration: PET Imaging for Characterization of Small Renal Masses.” His presentation will focus on:

• The use of advanced PET imaging techniques to improve characterization and differentiation of small renal tumors.
• The role of nuclear medicine in enhancing diagnostic accuracy and guiding clinical decision-making.
• Innovative imaging biomarkers and quantitative analysis methods for renal mass evaluation.
• Clinical implications of PET imaging integration in personalized renal cancer management.

With his extensive clinical and research expertise in nuclear medicine, Dr. Zhang emphasizes the transformative potential of PET imaging to advance early and precise diagnosis of renal tumors, improving patient outcomes.

Global Voices in Renal Oncology (VIRO) 2025